本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

诺和诺德

90.86
+3.363.84%
盘后91.500.6400+0.70%19:59 EST
成交量:801.17万
成交额:7.28亿
市值:4,033.32亿
市盈率:28.92
高:91.90
开:91.50
低:90.29
收:87.50
数据加载中...

公司资料

公司名字:
诺和诺德
交易所:
NYSE
成立时间:
1923
员工人数:
76826
公司地址:
Novo Alle 1,Bagsvaerd,Capital Region of Denmark,Denmark
邮编:
2880
传真:
- -
简介:
Novo Nordisk A/S成立于1989年,由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球医疗保健公司,也是糖尿病和肥胖症护理领域的全球领导者。该公司拥有广泛的糖尿病和肥胖症护理以及罕见疾病产品组合,包括用于治疗糖尿病和肥胖症的胰高血糖素样肽-1(GLP-1)受体激动剂、现代胰岛素和人胰岛素。

董事

名称
职位
Laurence Debroux
Chair of the Board
Andreas Fibig
Director
Christina Law
Director
Elisabeth Dahl Christensen
Director
Henrik Poulsen
Director
Jeppe Christiansen
Director
Kasim Kutay
Director
Liselotte Hyveled
Director
Martin Mackay
Director
Mette Bojer Jensen
Director
Sylvie Gregoire
Director
Thomas Rantzau
Director

股东

名称
职位
Camilla Sylvest
Executive vice president, Commercial Strategy & Corporate Affairs
David Moore
Executive vice president, U.S. Operations & Business Development
Henrik Wulff
Executive vice president, Product Supply, Quality & IT
Karsten Munk Knudsen
Executive vice president and chief financial officer
Lars Fruergaard Jorgensen
President and chief executive officer
Ludovic Helfgott
Executive vice president, Rare disease
Marcus Schindler
Executive vice president, Research & Early Development and chief scientific officer
Martin Holst Lange
Executive vice president, Development
Maziar Mike Doustdar
Executive vice president, International Operations
Tania Sabroe
Executive vice president, People & Organisation